Template:Current week ecosystem agenda: Difference between revisions

From Bioblast
mNo edit summary
No edit summary
Line 1: Line 1:


Β  2021 Week 27
Β  2021 Week 28


*'''Jul-05 Mo''' Β 
*'''Jul-12 Mo''' Β 
:{|


| width="100" align="center" |[[Image:O2k-Publications.jpg|70px|link=http://wiki.oroboros.at/index.php/O2k-Publications:_Topics |O2k-Publications in the MiPMap]]
|''' Early adipocyte hypertrophy is accompanied with decreased mitochondrial oxygen consumption and increased ROS formation''' <br>
:from the O2k-Network Β»[[DE Munich Zischka H]]Β«
*Baldini F, Fabbri R, Eberhagen C, Voci A, Portincasa P, Zischka H, Vergani L (2021) Adipocyte hypertrophy parallels alterations of mitochondrial status in a cell model for adipose tissue dysfunction in obesity. Life Sci 265:118812. [[Baldini 2021 Life Sci|Β»Bioblast linkΒ«]]
|}
----
----
*'''Jul-06 Tu''' Β 
*'''Jul-13 Tu''' Β 


----
*'''Jul-07 We'''
:{|
:{|
| width="110" align="center" | [[File:MitoPedia.jpg|left|80px|MitoPedia]]
| width="100" align="center" |[[Image:O2k-Publications.jpg|70px|link=http://wiki.oroboros.at/index.php/O2k-Publications:_Topics |O2k-Publications in the MiPMap]]
|'''TPP<sup>+</sup> for potentiometric detection of mt-membrane potential (mtMP) or fluorometry with safranin?'''<br>
|'''Dietary octanoate cannot rescue cardiomyopathy in CPT2 deficiency''' <br>
Safranin enables measurement of the relationship between fluorescence intensity and mtMP, and if linear, the absolute mtMP can be calculated. TPP<sup>+</sup> enables calibration for measurement of mtMP.<br>
from the O2k-Network Β»[[ US PA Pittsburgh Goetzman ES]]Β«
- Β»[https://wiki.oroboros.at/index.php/Safranin#TPP_vs_safranin TPP<sup>+</sup> vs safranin]Β«<br>
*Pereyra AS, Harris KL, Soepriatna AH, Waterbury QA, Bharathi SS, Zhang Y, Fisher-Wellman KH, Goergen CJ, Goetzman ES, Ellis JM (2021) Octanoate is differentially metabolized in liver and muscle and fails to rescue cardiomyopathy in CPT2 deficiency. J Lipid Res 62:100069Β  [[Pereyra 2021 J Lipid Res|Β»Bioblast linkΒ«]]
|}
|}
----
----
*'''Jul-14 We'''


*'''Jul-08 Th''' Β 
----
*'''Jul-15 Th''' Β 


----
----
*'''Jul-09 Fr'''
*'''Jul-16 Fr''' Β 
:{|
| width="100" align="center" | [[File:O2k-brief.png|45px|link=http://wiki.oroboros.at/index.php/O2k-brief|O2k-brief repository]]
|'''Doxorubicin-transferrin conjugate alters mitochondrial bioenergetics in breast cancer cells''' <br>
:from the O2k-Network Β»[[PL Lodz Watala C]]Β«
* Wigner P, Zielinski K, Labieniec-Watala M, Marczak A, Szwed M (2021) Doxorubicin-transferrin conjugate alters mitochondrial homeostasis and energy metabolism in human breast cancer cells. Sci Rep 11:4544.Β  [[Wigner 2021 Sci Rep|Β»Bioblast linkΒ«]]
|}

Revision as of 08:43, 12 July 2021

2021 Week 28
  • Jul-12 Mo

  • Jul-13 Tu
O2k-Publications in the MiPMap Dietary octanoate cannot rescue cardiomyopathy in CPT2 deficiency

from the O2k-Network Β»US PA Pittsburgh Goetzman ESΒ«

  • Pereyra AS, Harris KL, Soepriatna AH, Waterbury QA, Bharathi SS, Zhang Y, Fisher-Wellman KH, Goergen CJ, Goetzman ES, Ellis JM (2021) Octanoate is differentially metabolized in liver and muscle and fails to rescue cardiomyopathy in CPT2 deficiency. J Lipid Res 62:100069 Β»Bioblast linkΒ«

  • Jul-14 We

  • Jul-15 Th

  • Jul-16 Fr
O2k-brief repository Doxorubicin-transferrin conjugate alters mitochondrial bioenergetics in breast cancer cells
from the O2k-Network Β»PL Lodz Watala CΒ«
  • Wigner P, Zielinski K, Labieniec-Watala M, Marczak A, Szwed M (2021) Doxorubicin-transferrin conjugate alters mitochondrial homeostasis and energy metabolism in human breast cancer cells. Sci Rep 11:4544. Β»Bioblast linkΒ«
Cookies help us deliver our services. By using our services, you agree to our use of cookies.